Target intelligence / Profile preview

Antigen-presenting cell activation via dendritic cell recruitment

Molecular classification
Other (innate immune cell process; not a molecule, receptor, transporter, etc.)
01

Overview

"Antigen-presenting cell activation via dendritic cell recruitment" refers to an immunological process by which **dendritic cells** (DCs)—a specialized subset of antigen-presenting cells—are attracted to sites of inflammation or tumor by chemokines and other recruitment signals. Upon arrival, DCs interact with antigenic material, undergo maturation (upregulating MHC and costimulatory molecules), and present processed antigens to naïve T cells, thereby initiating adaptive immune responses. This process is central to immune surveillance, tumor immunity, and the regulation of self-tolerance and autoimmunity. Dysregulation can contribute to insufficient tumor immunity, infectious disease susceptibility, or excessive inflammation and autoimmunity.

Other names
Dendritic cell recruitment and activationAPC activation by dendritic cell recruitmentDendritic cell-mediated antigen-presenting cell activation
02

Mechanism of action

Modulation of costimulatory/cytokine pathways to enhance DC activation or block DC-T cell interactions Induction or inhibition of DC maturation and migration, thus affecting antigen presentation and T cell priming

03

Biological functions

Immune responseAntigen presentationAdaptive immunity initiationInflammation regulationTumor surveillance
04

Disease associations

CancerAutoimmune diseasesInfectionInflammation
05

Safety considerations

Risks of excessive immune activation or cytokine release (immunotherapy-related adverse events)Risk of autoimmunity or immune-related tissue damage due to heightened DC activationInsufficient immune response or tolerance induction if DC recruitment/activation is impaired
06

Interacting drugs

Biological agents targeting costimulatory molecules (e.g., CTLA-4-Ig, LFA-3-Ig, anti-CD3 monoclonal antibody)

1 more in the full profile.

07

Biomarkers

Surface proteins indicating DC maturation (e.g., CD80, CD86, MHC class II, CCR7)Cytokines/chemokines linked to DC recruitment and activation (e.g., CCL5, CCL4, XCL1, type I IFNs)

Beyond the preview

Go deeper on Antigen-presenting cell activation via dendritic cell recruitment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell activation via dendritic cell recruitment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call